BeOne Medicines AG, an oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally. The company's commercial stage products include BRUKINSA, a small molecule inhibitor of Bruton's Tyrosine Kinase (BTK) for...
289 insider sale filings on record · latest filing 2026-10-15.
No open-market insider purchases (SEC Form 4 code P) on record for ONC.